Welcome to our dedicated page for MSP Recovery SEC filings (Ticker: MSPR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
MSP Recovery, Inc. filings document the company's reimbursement recovery business and its public-company capital structure. Recent Form 8-K reports center on material definitive agreements involving subsidiary funding arrangements, working capital credit facility disclosures and operating-expense financing. The filings identify Class A common stock and redeemable warrants traded on the OTC Market Group under MSPR, MSPRW and MSPRZ.
The company's regulatory record also includes reporting-status disclosures, including a Form 12b-25 notification related to a delayed annual report. Those filings describe liquidity constraints, reliance on loan funding, evaluation of financing and reorganization alternatives, and risks around continued reporting. Periodic reports and current reports provide formal disclosure on governance, capital structure, material agreements, risk factors and the financial reporting framework for MSP Recovery's recovery and technology operations.
MSP Recovery, Inc. files a prospectus supplement to register up to 909,982 shares of Class A Common Stock, up to 755,200,000 warrants to purchase Class A Common Stock, and up to 236,019 shares issuable upon exercise of warrants.
The supplement describes resale by selling securityholders of various share groups (Founder Shares, Private Units, Up-C exchangeable shares and other contract issuances) and discloses that cash proceeds to the company are expected to be nominal from the Public Warrants (less than $500) and that the company will not retain proceeds from the New Warrants. The filing also attaches a Form 8-K disclosing one-time advances: a $0.1 million discretionary Operational Collection Floor advance from Hazel Partners Holdings, LLC and a $0.1 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC; both advances are described as standalone, discretionary accommodations and do not create ongoing committed liquidity.
MSP Recovery, Inc. files a prospectus supplement registering 56,896 shares of Class A Common Stock for resale.
The supplement states the registered shares include 28,572 shares issuable upon exercise of VRM Warrants, 2,858 issued and 14,286 issuable to VRP, and 11,180 issued to Palantir. The VRM and VRP warrants have a $0.0175 exercise price, producing only nominal proceeds if exercised.
The filing also discloses two one-time advances: a $0.1 million advance from Hazel Partners (March 23, 2026) and a $0.1 million recovery-proceeds advance from VRM (March 20, 2026), each described as standalone accommodations with no commitment for further funding.
MSP Recovery, Inc. disclosed two small, one-time funding arrangements that highlight its constrained liquidity. Through a Hazel Partners Holdings LLC working capital facility, Hazel agreed in its sole discretion to fund a $0.1 million advance for operating expenses under the Operational Collection Floor, funded on March 23, 2026. This advance does not reinstate or reopen any broader availability under the facility, and the company states it has no rights to and no reasonable basis to expect further advances from Hazel.
Separately, MSP Recovery entered into a letter agreement with VRM MSP Recovery Partners, LLC, under which VRM made a one-time advance of recovery proceeds of $0.1 million to support accounts payable. The company must reimburse VRM for this advance and certain prior permitted uses of VRM’s recovery proceeds promptly upon closing of any future loan or other financing, including any debtor-in-possession financing if it operates under Chapter 11 protection. Both fundings are explicitly characterized as one-time accommodations and do not provide ongoing or recurring liquidity.
MSP Recovery, Inc. files a prospectus supplement registering up to 32,220 shares of Class A common stock for resale by selling securityholders, including up to 15,239 shares issuable upon exercise of a CPIA Warrant.
The supplement attaches a Form 8-K describing two one-time advances of $0.2 million each from Hazel Partners Holdings, LLC and VRM MSP Recovery Partners, LLC to support operations and accounts payable, respectively, and states the Hazel advance is discretionary and does not reopen facility capacity. The filing discloses the resignation of director Ophir Sternberg and CFO Francisco Rivas-Vasquez, and notes a 1-for-7 reverse split effective September 1, 2025. Share and per-share figures in the supplement are adjusted for the reverse split.
MSP Recovery, Inc. amends its prospectus to register up to 909,982 shares of Class A Common Stock, up to 755,200,000 New Warrants, and up to 236,019 shares issuable upon warrant exercises, for resale by selling securityholders.
The supplement discloses that Public Warrants (exercise price $0.4375) are likely to be exercised but would generate nominal proceeds, while New Warrants (exercise price $50,312.50) are unlikely to be exercised given the market price. The filing also reports two one-time advances—$0.2M from Hazel Partners and $0.2M from VRM—to provide short-term liquidity, and the resignations of a director and the CFO (February 2026).
MSP Recovery, Inc. files a prospectus supplement to register 56,896 shares of Class A common stock for resale by selling securityholders, including warrants and shares issued to Virage entities and Palantir, adjusted for a 1-for-7 reverse split.
The supplement attaches a Form 8-K that discloses two short-term one-time advances: a $0.2 million discretionary advance from Hazel Partners under the existing working capital facility and a $0.2 million one-time advance from VRM to support accounts payable, each described as non-recurring and not creating ongoing funding commitments. The 8-K also reports the immediate resignations of director Ophir Sternberg and CFO Francisco Rivas-Vasquez.
MSP Recovery, Inc. is registering 285,715 shares of Class A Common Stock for resale by a selling securityholder under Prospectus Supplement No. 57.
The resale registration covers shares originally issued or issuable to YA II PN, Ltd. (Yorkville) under the Standby Equity Purchase Agreement (the Yorkville SEPA). The Yorkville SEPA contemplates purchases of up to $250 million of Class A Common Stock, but is subject to an Ownership Limitation of 9.99% and an Exchange Cap that was effectively lifted January 8, 2025. The prospectus supplement incorporates the Company’s Form 8-K disclosure, which also describes Yorkville Convertible Notes with aggregate advances and specified conversion pricing and a variety of amendments to pricing floors, maturities, and other terms.
MSP Recovery, Inc. disclosed two small, one-time funding arrangements and key leadership departures. The company obtained a $0.2 million discretionary advance from Hazel Partners Holdings LLC under its working capital credit facility and a separate $0.2 million one-time advance of recovery proceeds from VRM MSP Recovery Partners, LLC, both primarily for operating needs and accounts payable.
The company emphasizes that its Hazel facility remains fully discretionary, provides no committed liquidity, and that it has no rights to and no reasonable basis to expect further advances. It also states that the VRM advance does not imply any obligation for future funding. In addition, director Ophir Sternberg resigned from the board, and Francisco Rivas‑Vasquez resigned as Chief Financial Officer, with both departures described as not due to disagreements over operations, policies, or practices.
MSP Recovery, Inc. filed a prospectus supplement covering the resale of up to 56,896 shares of Class A common stock by selling securityholders. The shares include stock issued or issuable to Virage-affiliated entities under prior agreements and 11,180 shares issued to Palantir Technologies as compensation for products and services. Warrants tied to part of these shares have a low $0.0175 per share exercise price, so any cash the company receives from exercises would be only nominal.
Attached to the supplement, MSP Recovery reported a new letter agreement with Hazel Partners Holdings under its existing working capital credit facility. Hazel funded a one-time $250,000 advance on January 26, 2026 to be used primarily for operating expenses, increasing the Operational Collection Floor beyond its prior level. The company emphasizes this is a standalone accommodation, does not restore ongoing availability, and that it has no rights to, and no reasonable basis to expect, further advances or committed liquidity under this facility.
MSP Recovery, Inc. files a prospectus supplement covering the resale of up to 909,982 shares of Class A common stock and up to 755,200,000 warrants, plus the issuance of up to 236,019 shares upon warrant exercise. The supplement also attaches a new current report.
The report describes a $250,000 one-time advance under the discretionary Working Capital Credit Facility with Hazel Partners Holdings LLC, to be used primarily for operating expenses. The company stresses this advance is a standalone accommodation that does not reinstate or reopen availability, creates no commitment for future funding, and provides no ongoing liquidity, and states it has no reasonable basis to expect further advances under the facility.